Evidence map›Paper›PMID 35156682›Full record

ArticleDevelopment (Cambridge, England)2022

Microfluidic systems for modeling human development.

Makenzie G Bonner, Hemanth Gudapati, Xingrui Mou, Samira Musah

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Kidney Disease Modeling with Organoids and Organs-on-Chips.Annual review of biomedical engineering · 2024
    Review
  7. Article
  8. Current strategies using 3D organoids to establishJournal of veterinary science · 2024
    Review
  9. Article
  10. Review
  11. Modeling development using hydrogels.Development (Cambridge, England) · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Makenzie G BonnerDevelopmental and Stem Cell Biology Program, Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-1489-4127
Hemanth GudapatiDepartment of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA.ORCID 0000-0001-9610-8873
Xingrui MouDepartment of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA.ORCID 0000-0002-4258-672X
Samira MusahDevelopmental and Stem Cell Biology Program, Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0001-9432-6789

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proper development and patterning of organs rely on concerted signaling events emanating from intracellular and extracellular molecular and biophysical cues. The ability to model and understand how these microenvironmental factors contribute to cell fate decisions and physiological processes is crucial for uncovering the biology and mechanisms of life. Recent advances in microfluidic systems have provided novel tools and strategies for studying aspects of human tissue and organ development in ways that have previously been challenging to explore ex vivo. Here, we discuss how microfluidic systems and organs-on-chips provide new ways to understand how extracellular signals affect cell differentiation, how cells interact with each other, and how different tissues and organs are formed for specialized functions. We also highlight key advancements in the field that are contributing to a broad understanding of human embryogenesis, organogenesis and physiology. We conclude by summarizing the key advantages of using dynamic microfluidic or microphysiological platforms to study intricate developmental processes that cannot be accurately modeled by using traditional tissue culture vessels. We also suggest some exciting prospects and potential future applications of these emerging technologies.

Indexed as

Models, BiologicalHeartHumansLab-On-A-Chip DevicesMicrofluidicsPolyestersPrinting, Three-DimensionalTissue EngineeringPolyesterspoly(L-lactide-co-glycolide-co-epsilon-caprolactone)BiophysicsIn vitro modelsMicrofluidicsMicrophysiological systemsOrgans-on-chipsTissue engineering

Identifiers

PMID35156682
PMCPMC8918817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.